Expanding the armamentarium for the treatment of Clostridium difficile infection.

  title={Expanding the armamentarium for the treatment of Clostridium difficile infection.},
  author={Simon D Goldenberg},
  journal={The Lancet. Infectious diseases},
  volume={17 7},
Citing this paper Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination, volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are again advised to check the publisher's website for any subsequent… CONTINUE READING

Topics from this paper.


Publications referenced by this paper.

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection : a phase 2 , randomised , double - blind , activecontrolled , noninferiority study

RJ Vickers, GS Tillotson, R Nathan
  • Lancet Infect Dis
  • 2017

Risk factors for recurrence , complications and mortality in Clostridium difficile infection : a systematic review

CN AbouChakra, J Pepin, S Sirard, L Valiquette
  • PLoS One
  • 2014

Can we identify patients at high risk of recurrent Clostridium difficile infection?

  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2012